Comparison of outcomes of four different treatment modalities for diabetic vitreous haemorrhage.

Taskintuna, Ibrahim; Elsayed, Maram E A Abdalla; Taskintuna, Kaan; Ahmad, Khabir; Khandekar, Rajiv; Schatz, Patrik; Kozak, Igor

Taskintuna, Ibrahim; Elsayed, Maram E A Abdalla; Taskintuna, Kaan; Ahmad, Khabir; Khandekar, Rajiv; Schatz, Patrik; Kozak, Igor.

Affiliation

Taskintuna I; Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia. itaskintuna@kkesh.med.sa.
Elsayed MEAA; Jeddah Eye Hospital, Jeddah, Kingdom of Saudi Arabia.
Taskintuna K; Research Department, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
Ahmad K; Research Department, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
Khandekar R; Research Department, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
Schatz P; Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
Kozak I; Department of Clinical Sciences, Ophthalmology, Lund University, Lund, Sweden.

Sci Rep ; 10(1): 3674, 2020 02 28.

Article de En | MEDLINE | ID: mdl-32111892

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vitrectomie / Hémorragie du vitré / Complications du diabète / Bévacizumab Type d'étude: Etiology_studies / Observational_studies / Risk_factors_studies Limites: Adult / Aged / Humans / Middle aged Langue: En Journal: Sci Rep Année: 2020 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google